-
Enfuvirtide (INN), sold
under the
brand name
Fuzeon, is an HIV
fusion inhibitor, the
first of a
class of
antiretroviral drugs used in
combination therapy...
- Pulmozyme, Tamiflu, Valcyte, Anaprox, Cytovene, EC-Naprosyn, Erivedge,
Fuzeon, Invirase, Klonopin, Kytril, Naprosyn, Rocephin, Roferon-A, Romazicon, Valium...
- fibrosis.
Fansidar (sulfadoxine/pyrimethamine), for
malaria and toxoplasmosis.
Fuzeon (enfuvirtide), for
salvage therapy of HIV-1 infection.
Gazyva (obinutuzumab)...
- and
begins its replication. Recently,
inhibitors derived from HR2 such as
Fuzeon (DP178, T-20) that bind to the HR1
region on gp41 have been developed. However...
-
entry inhibitors—a
biomimetic peptide called Enfuvirtide, or the
brand name
Fuzeon—has
received FDA
approval and has been in use for some time. Potentially...
-
fulvestrant Fulvicin P/G 165
Fulvicin P/G 330
Fulvicin P/G Fulvicin-U/F
Furadantin Furoscix furosemide Fusilev Fuzeon Fyarro Fyavolv Fycompa Fyremadel...
-
liquid phase synthesis. Thus, for the
production of Roche's anti-AIDS drug
Fuzeon (enfuvirtide),
three fragments of 10–12
amino acids are
first made by solid-phase...
-
Laboratories for
pricing discounts in
exchange for
providing blind patient data on
Fuzeon medication. In
November 2007
Company signed an
exclusive distribution agreement...
